Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer
2006 · British Journal of Cancer · 157 citations
https://doi.org/10.1038/sj.bjc.6603383
U
Ulf Aasebø
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
3.4K
Citations
27
h-index
44
i10-index
Ulf Aasebø is an academic researcher from University Hospital of North Norway. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Lung Cancer Diagnosis and Treatment. The author has an h-index of 27, co-authored 69 publications.
Papers by this author
worksLow oxygen saturation and mortality in an adult cohort: the Tromsø study
2015 · BMC Pulmonary Medicine · 83 citations
https://doi.org/10.1186/s12890-015-0003-5
Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group
2013 · British Journal of Cancer · 63 citations
https://doi.org/10.1038/bjc.2013.466
How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial
2014 · Clinical Lung Cancer · 22 citations
https://doi.org/10.1016/j.cllc.2014.08.005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat